Topic: Adipose tissue inflammation in patients with coronary artery disease and type 2 diabetes; effects on exercise training.
Schultz NH, Holme PA, Henriksson CE, Mowinckel MC, Sandset PM, Bratseth V, Jacobsen EM(2019) The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis Thromb Res, 177, 154-156(in press) DOI 10.1016/j.thromres.2019.03.010, PubMed 30903875
Holte KB, Svanteson M, Hanssen KF, Haig Y, Solheim S, Berg TJ(2019) Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study J Diabetes Complications(in press) DOI 10.1016/j.jdiacomp.2019.01.006, PubMed 30846232
Solberg OG, Stavem K, Ragnarsson A, Beitnes JO, Skårdal R, Seljeflot I, Ueland T, Aukrust P, Gullestad L, Aaberge L(2019) Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study Catheter Cardiovasc Interv(in press) DOI 10.1002/ccd.28157, PubMed 30790446